(Q54424684)

English

Prophylactic post-transplant dasatinib administration in a pediatric patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23782380

Prophylactic post-transplant dasatinib administration in a pediatric patient with Philadelphia chromosome-positive acute lymphoblastic leukemia. (English)

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23782380

1 reference

based on heuristic

inferred from title

dasatinib monohydrate

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Akihiro Watanabe

1

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23782380

Shin Chansu

2

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23782380

Atsushi Ogawa

3

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23782380

Keiko Asami

4

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23782380

Masaru Imamura

5

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23782380

publication date

1 June 2013

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23782380

Pediatrics International

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23782380

55

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23782380

3

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23782380

e56-8

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23782380

Philadelphia chromosome-positive acute lymphoblastic leukemia in children: new and emerging treatment options

1 reference

https://api.crossref.org/works/10.1111%2FPED.12019

21 January 2018

How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FPED.12019

21 January 2018

Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study

1 reference

https://api.crossref.org/works/10.1111%2FPED.12019

21 January 2018

Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study

1 reference

https://api.crossref.org/works/10.1111%2FPED.12019

21 January 2018

Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).

1 reference

https://api.crossref.org/works/10.1111%2FPED.12019

21 January 2018

Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FPED.12019

21 January 2018

In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants

1 reference

https://api.crossref.org/works/10.1111%2FPED.12019

21 January 2018

Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortium

1 reference

https://api.crossref.org/works/10.1111%2FPED.12019

21 January 2018

Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion

1 reference

https://api.crossref.org/works/10.1111%2FPED.12019

21 January 2018

Dasatinib after allogeneic stem cell transplantation in a child with Philadelphia chromosome positive acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FPED.12019

21 January 2018

Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005.

1 reference

https://api.crossref.org/works/10.1111%2FPED.12019

21 January 2018

Identifiers

10.1111/PED.12019

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23782380

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23782380

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54424684&oldid=1584492144"